Similar results were seen within CD8+ tumour infiltrating lymphocytes (TILs; Supplementary Fig. 1e) isolated from sub-cutaneous (s.c.)B16-OVA transgenic tumours 14 days after inoculation. This evidence concerns the gene CD8A and neoplasm.